stella
beta
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia — Stella
Recruiting
Back to Focal Hand Dystonia trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Trial locations
(5 sites)
Switzerland
Inselspital - University Hospital Berne, Bern
Centre hospitalier universitaire vaudois (CHUV), Lausanne
Neurocentro della Svizzera Italiana, Lugano
Neurocenter of St. Gallen, Sankt Gallen
USZ- Univerity Hospital Zurich, Zurich
View full record on ClinicalTrials.gov